Galileo Biotech

General Information

Company Name

Galileo Biotech

Founded Year

2015

Location (Offices)

Brazil +2

Founders / Decision Makers

Number of Employees

Industries

Biotechnology, Manufacturing

Funding Stage

Social Media

Galileo Biotech - Company Profile

Galileo Biotech was successfully acquired by San Diego-based Antharis Therapeutics Inc., in August 2023. The company, now a wholly-owned subsidiary of Antharis Therapeutics, is headquartered in San Diego, USA. Its state-of-the-art R&D laboratory and certified production facility is located in the city of Rio de Janeiro Brazil. Galileo is a science-driven company focused on the development and production of in-vitro diagnostics products and cutting-edge therapeutic monoclonal antibodies for devastating human diseases, in particular cancer. Founded in 2015, Galileo Biotech operates in the Biotechnology and Manufacturing industries.

Taxonomy: biotherapeutics, diagnostics, monoclonal antibodies, immunology, cancer, in-vitro diagnostics, therapeutic antibodies, R&D, production facility, human health, animal health, ELISA, antibody, immunochemistry